 "Fin services firms buys Strides Arcolab scrips worth Rs 66 cr")
BNP Paribas Arbitrage purchased 5.03 lakh shares of Strides Arcolab for an estimated Rs 38.21 crore, as per information available with the stock exchanges.
Macquarie Bank bought 3.5 lakh shares of the drug firm for about Rs 28 crore, the data showed.
Also Read
BNP Paribas Arbitrage picked up Strides Arcolab shares on an average price of Rs 759.72, while Macquarie Bank bought the drug firm company scrips at Rs 799.97 apiece.
As on June quarter, BNP Paribas Arbitrage, held 10.01 lakh shares, amounting to 1.7% stake, of Strides Arcolab.
Shares of Strides Arcolab were in focus during past one week, soared 38% from Rs 589 on July 31, after the company received tentative approval from the US health regulator for anti-AIDS combination drug.
Strides Arcolab today rallied 16.83% to close at Rs 811.30 apiece on the BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%